Literature DB >> 10961964

Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease.

S Fichtlscherer1, G Rosenberger, D H Walter, S Breuer, S Dimmeler, A M Zeiher.   

Abstract

BACKGROUND: Elevated C-reactive protein (CRP) serum levels, an exquisitely sensitive objective marker of inflammation, relate to long-term prognosis in patients with coronary artery disease and in apparently healthy men. Because abnormalities of endothelial regulation of vascular function may contribute to the occurrence of coronary events, we tested the hypothesis that elevated CRP levels are associated with an abnormal systemic endothelial vascular reactivity. METHODS AND
RESULTS: Endothelium-dependent (10 to 50 microg/min acetylcholine) and endothelium-independent (2 to 8 microg/min sodium nitroprusside) forearm blood flow responses were measured with venous occlusion plethysmography in 60 male patients with angiographically documented coronary artery disease. Forearm blood flow responses to acetylcholine were inversely correlated with CRP serum levels (r=-0.46, P:=0.001). With multivariate analysis that included the classic risk factors for coronary artery disease, elevated CRP serum level remained a statistically significant independent predictor of a blunted endothelial vasodilator capacity. Most important, normalization of elevated CRP levels over time was associated with a normalization of endothelium-mediated forearm blood flow responses after 3 months.
CONCLUSIONS: Thus, elevated CRP serum levels indicative of a systemic inflammatory response are associated with a blunted systemic endothelial vasodilator function. The identification of elevated CRP levels as a transient independent risk factor for endothelial dysfunction might provide an important clue to link a systemic marker of inflammation to atherosclerotic disease progression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10961964     DOI: 10.1161/01.cir.102.9.1000

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  107 in total

1.  Beyond the cholesterol profile: monitoring therapeutic effectiveness of statin therapy.

Authors:  R G Schwartz
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

Review 2.  C-reactive protein and risk of cardiovascular disease: evidence and clinical application.

Authors:  Paul M Ridker; Shari S Bassuk; Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

3.  C reactive protein and microvascular function.

Authors:  F Tomai
Journal:  Heart       Date:  2004-07       Impact factor: 5.994

4.  Coupling of Fcγ receptor I to Fcγ receptor IIb by SRC kinase mediates C-reactive protein impairment of endothelial function.

Authors:  Nathan C Sundgren; Weifei Zhu; Ivan S Yuhanna; Ken L Chambliss; Mohamed Ahmed; Keiji Tanigaki; Michihisa Umetani; Chieko Mineo; Philip W Shaul
Journal:  Circ Res       Date:  2011-09-22       Impact factor: 17.367

5.  Elevations in C-reactive protein and endothelin-1 system activity in humans.

Authors:  Caitlin A Dow; Danielle L Templeton; Grace M Lincenberg; Jared J Greiner; Brian L Stauffer; Christopher A DeSouza
Journal:  Life Sci       Date:  2015-12-11       Impact factor: 5.037

6.  Association of promoter region single nucleotide polymorphisms at positions -819C/T and -592C/A of interleukin 10 gene with ischemic heart disease.

Authors:  Gyeong-Im Yu; Ho-Chan Cho; Yun-Kyeong Cho; Hyoung-Seob Park; Hyuck-Jun Yoon; Hyung-Seop Kim; Chang-Wook Nam; Yoon-Nyun Kim; Kwon-Bae Kim; Eunyoung Ha; Dong-Hoon Shin; Seung-Ho Hur
Journal:  Inflamm Res       Date:  2012-05-17       Impact factor: 4.575

7.  Brachial artery low-flow-mediated constriction is increased early after coronary intervention and reduces during recovery after acute coronary syndrome: characterization of a recently described index of vascular function.

Authors:  Jonathan R Spiro; Janet E Digby; Gopal Ghimire; Mark Mason; Andrew G Mitchell; Charles Ilsley; Ann Donald; Miles C D Dalby; Rajesh K Kharbanda
Journal:  Eur Heart J       Date:  2010-10-29       Impact factor: 29.983

Review 8.  Endothelial function and inflammation in coronary artery disease.

Authors:  D Tousoulis; M Charakida; C Stefanadis
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

9.  Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease.

Authors:  Y F Cheung; M H K Ho; S C F Tam; T C Yung
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

10.  Correlation of epicardial and systemic flow-mediated vasodilation in patients with atypical angina but no evidence of atherosclerotic disease.

Authors:  Katja B Vallbracht-Israng; Andreas Morguet; Peter L Schwimmbeck
Journal:  Can J Cardiol       Date:  2007-11       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.